Bladder (ICRU) dose point does not predict urinary acute toxicity in adjuvant isolated vaginal vault high-dose-rate brachytherapy for intermediate-risk endometrial cancer

PURPOSE: High-dose-rate brachytherapy (HDR-BT) alone is an adjuvant treatment option for stage I intermediaterisk endometrial cancer after complete surgical resection. The aim of this study was to determine the value of the dose reported to ICRU bladder point in predicting acute urinary toxicity. On...

Descripción completa

Detalles Bibliográficos
Autores principales: Sapienza, Lucas Gomes, Aiza, Antonio, Gomes, Maria José Leite, Chen, Michael Jenwei, Pellizzon, Antonio Cassio de Assis, Mansur, David B., Baiocchi, Glauco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663209/
https://www.ncbi.nlm.nih.gov/pubmed/26622241
http://dx.doi.org/10.5114/jcb.2015.54952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663209/
https://www.ncbi.nlm.nih.gov/pubmed/26622241
http://dx.doi.org/10.5114/jcb.2015.54952

Ejemplares similares